SIAS
ALDR

Shine Investment Advisory Services’s Alder Biopharmaceuticals ALDR Stock Holding History

Shine Investment Advisory Services’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-490
Closed -$9K – 787
2019
Q3 		$9K Buy
+490
New +$5.6K ﹤0.01% 582

Shine Investment Advisory Services's ALDR Position: Q4 2019 in Review

Shine Investment Advisory Services sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 490 shares — an estimated $9K sold.

Shine Investment Advisory Services first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $9K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Shine Investment Advisory Services reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Shine Investment Advisory Services sold 490 Alder Biopharmaceuticals shares in Q4 2019, an estimated $9K.
  • Shine Investment Advisory Services first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Shine Investment Advisory Services's Alder Biopharmaceuticals position peaked at $9K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Shine Investment Advisory Services's 13F filing for Q4 2019, filed 3 Feb 2020.